Pharmacy and Drug Innovations : Open Access

About the Journal

Google Scholar
Journal Impact Factor: 2.7*
Pharmacy and Drug Innovations (JPDI)
is designed to compact with the various research areas related to pharmaceutical sciences. Journal considers studies from basic research to clinical exploration as research articles, reviews, meta-analyses, reviews, mini-reviews, short communications, and editorials from the world scientific community pertaining to development of new systems, methods and techniques in pharmacy education and practice, drug design, drug discovery, pharmacogenomics, formulation, drug specificity, optimizing dosage regimen, drug delivery systems and regulation, personalized medicine, testing the efficacy of drug molecule in vitro and in vivo studies, pharmacokinetics, analytical sciences, nanotechnology, therapeutic aspects, quality control, optimization by medicinal chemistry, drug pharmacodynamics, evaluation of safety and toxicity of drug molecules, regulatory science as well as computational approaches.  Therefore, the journal welcomes submissions from all over the globe.

The range of the journal also broaden to cover advancements in toxicology, cell and molecular biology, biomedical research, clinical and pharmaceutical microbiology, pharmaceutical biotechnology, medicinal chemistry, phytochemistry, Virtual chemistry and nutraceuticals.

We welcome pharmacists, academicians, researchers, scholars, clinicians, and scientists to submit their research work that promote the advances in newly improved drug molecules and their uses involving pharmaceutical aspects to the scientific community.

The journal picks up the pace to top quality articles which are an outcome from dynamic peer review process. We follow double blind peer review process which remains confidential and the identities of the reviewers and the authors are not revealed. Editorial Board Members of JPDI or outside experts related to the field carry out the review process; at least two independent reviewer’s approval followed by the editor decision is required for the acceptance of any citable manuscript.

PDI strongly supports the Open Access initiative and follows the COPE guidelines. All published articles will be assigned DOI provided by the Cross Ref.

Open Access Publication and Creative Commons Licensing:

This is an online open access bimonthly journal, and all articles published under this are distributed under the terms of the Creative Commons Attribution-Non Commercial-Share A like 4.0 License, which allows others to remix, share, tweak, and build upon the work non-commercially, as long as proper credit is given and the new conception are licensed under the identical terms.

Ahead of Print policy:

Articles published online under the Ahead of Print models are regarded as published and can be cited and quoted using the DOI as the reference source or with citation provided for every article. Aditum has a policy that corrections will not be made after publication of an article online without following accepted measures for making necessary corrections to the scientific record.

You can use this list to carry out a final check of your submission before you send it to the journal for review else you can coordinate with editorial coordinator for any queries.

Key Words



Pharmaceutical drugs

Drug Dosage

Drug delivery

Drug designing

Drug discovery

Drug disposition

Drug safety

Pharmaceutical Microbiology


Drug Toxicology

Physical Pharmacy


Regulatory Affairs

Targeted drug delivery

Chemical Biology Drug Design

Combinatorial chemistry

Compound Management

Drug-Chemical Interactions

Herbal Drug Development

High-throughput screening

In Silico Drug Design

Molecular Docking

Molecular Drug Design

Molecular Pharmacology

Nano-materials in Drug Designing

Pharmaceutical Biotechnology

Pharmaceutical toxicology


Rational Drug Design

Regulatory sciences